WINNETKA, Calif., May 29, 2014 /PRNewswire/ -- Green Cures
& Botanical Distribution, Inc. (OTC Pink: GRCU) ("Green Cures")
announced today that it will introduce its first CDB derived
product to the public during the month of June 2014, and also provided a corporate
update.
Green Cures is pleased to announce the addition of CBD Capsules
to its line of products in the upcoming weeks. Green Cures'
set of 30 CBD Capsules will initially contain 50 milligrams of Pure
CBD-Hemp Oil per capsule. Green Cures' CBD Capsules do not contain
controlled substances, as their low THC content falls within
federal guidelines. Therefore, Green Cures will be able to market,
distribute and sell its upcoming product online and through
retailers across the nation. Cannabidiol (CBD) has been the subject
of numerous scientific studies at several academic research centers
in the United States and across
the globe. It is the second most prominent ingredient found in the
Cannabis plant, accounting for up to 40% of the plant's extract.
According to published scientific and clinical studies, CBD may act
in the form of an experimental model to improve a wide range of
conditions, including epilepsy, arthritis, rheumatoid, diabetes,
alcoholism, chronic pain, schizophrenia, antibiotic-resistant
infections, and other neurological disorders.
Additionally, Management of Green Cures announced that Green
Cures is exploring additional opportunities to expand its services
and operations within the hemp and cannabis industry, particularly,
in the field of agriculture. "Currently, in the United States, the demand for high quality
raw material throughout the hemp industry and cannabis medicinal
field outstrips the supply; therefore, we are exploring the
possibility of being able to supply raw materials for our current
and upcoming products, domestically and internationally," said
Green Cures CEO Robert Calkin.
At the present time, Green Cures plans to form its first subsidiary
company, which will operate in the field of agriculture, as
permitted by law. Furthermore, Green Cures is reviewing and has
been in negotiations with several highly qualified individuals in
the fields of horticulture and microbiology, with a view to their
potentially joining the new subsidiary in the near future.
Green Cures is also pleased to announce that it has received an
exclusive invitation to be part of the "International Cannabis
Association" exposition scheduled for June
22, 2014, in Las Vegas,
Nevada, where Green Cures will proudly showcase its current
and upcoming line of products and services available to the public,
as of the date of that event.
In closing, the company will be providing additional updates as
they become available.
About Green Cures & Botanical Distribution,
Inc.: (www.gcbdinc.com) Green Cures & Botanical
Distribution Inc. (GRCU) operates a diverse portfolio of services
and products within the botanical and medical cannabis industry, as
permitted by law. The products include nutritional
supplements, vitamins, minerals, herbs/botanicals, sports
nutrition, and specialty. In this rapidly growing industry of
alternative care and medicinal products, GRCU also provides to the
online community portals that supply with information and resources
regarding the benefits of cannabis-derived products.
FDA Statement: The statements contained in this document have
not been evaluated or approved by the FDA. The products and
statements referenced in this document are not intended to
diagnose, treat, cure, or prevent any disease.
Forward-looking statement: This press release may contain
certain forward-looking statements and information, as defined
within the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934, and is subject
to the Safe Harbor created by those sections. This material
contains statements about expected future events and/or financial
results that are forward-looking in nature and subject to risks and
uncertainties. Forward-looking statements are identified by wording
such as "scheduled (future sense)" "intend(s)", "plan(s)"
"expect(s)", "believe(s)" "will" "estimate(s)", "anticipate(s)",
"expect(s)", "may", "would", "could" or "should" or, in each case,
the negative thereof, other variations thereon, comparable
terminology that implies anticipated future deliverables. The
Company disclaims any obligation or intention to update any
forward-looking statement for any reason.
SOURCE Green Cures & Botanical Distribution, Inc.